1. Home
  2. CTLT vs CACI Comparison

CTLT vs CACI Comparison

Compare CTLT & CACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTLT
  • CACI
  • Stock Information
  • Founded
  • CTLT 2007
  • CACI 1962
  • Country
  • CTLT United States
  • CACI United States
  • Employees
  • CTLT N/A
  • CACI N/A
  • Industry
  • CTLT Biotechnology: Pharmaceutical Preparations
  • CACI EDP Services
  • Sector
  • CTLT Health Care
  • CACI Technology
  • Exchange
  • CTLT Nasdaq
  • CACI Nasdaq
  • Market Cap
  • CTLT 11.0B
  • CACI 12.7B
  • IPO Year
  • CTLT 2014
  • CACI 1979
  • Fundamental
  • Price
  • CTLT $59.12
  • CACI $465.40
  • Analyst Decision
  • CTLT Hold
  • CACI Buy
  • Analyst Count
  • CTLT 7
  • CACI 11
  • Target Price
  • CTLT $59.83
  • CACI $547.20
  • AVG Volume (30 Days)
  • CTLT 1.9M
  • CACI 203.4K
  • Earning Date
  • CTLT 11-05-2024
  • CACI 10-23-2024
  • Dividend Yield
  • CTLT N/A
  • CACI N/A
  • EPS Growth
  • CTLT N/A
  • CACI 22.78
  • EPS
  • CTLT N/A
  • CACI 20.19
  • Revenue
  • CTLT $4,422,000,000.00
  • CACI $7,866,574,000.00
  • Revenue This Year
  • CTLT $8.58
  • CACI $10.99
  • Revenue Next Year
  • CTLT $7.95
  • CACI $5.09
  • P/E Ratio
  • CTLT N/A
  • CACI $23.32
  • Revenue Growth
  • CTLT 4.71
  • CACI 13.24
  • 52 Week Low
  • CTLT $36.74
  • CACI $314.06
  • 52 Week High
  • CTLT $61.20
  • CACI $588.26
  • Technical
  • Relative Strength Index (RSI)
  • CTLT 45.31
  • CACI 31.06
  • Support Level
  • CTLT $59.34
  • CACI $490.27
  • Resistance Level
  • CTLT $60.21
  • CACI $581.06
  • Average True Range (ATR)
  • CTLT 0.52
  • CACI 14.89
  • MACD
  • CTLT 0.02
  • CACI -9.06
  • Stochastic Oscillator
  • CTLT 43.08
  • CACI 0.83

About CTLT Catalent Inc.

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

Share on Social Networks: